Cholecystitis or cholestasis after total gastrectomy and esophagectomy.
OBJECTIVE
Increased incidences of gallbladder disorders after esophagectomy and gastrectomy have been reported. Moreover, several researchers have reported increased incidences of gallbladder diseases in patients receiving long-term total parenteral nutrition. We studied the incidence of cholecystitis or cholestasis and determined its relationship with total parenteral nutrition; further, we compared the incidence after esophagectomy and after total gastrectomy.


METHODS
We retrospectively studied 109 patients who underwent total gastrectomy or esophagectomy. These patients were divided into 2 groups, those who underwent total gastrectomy (TG group) and those who underwent esophagectomy (E group).


RESULTS
The 2 groups did not significantly differ with respect to the mean duration of perioperative administration of total parenteral nutrition and the incidence rate of cholecystitis or cholestasis after esophagectomy.


CONCLUSIONS
Postoperative hyperbilirubinemia after esophagectomy may not contribute to the development of gallbladder complications. We suggest that parenteral modalities such as tube feeding be initiated immediately after surgery for preventing gallbladder complications after esophagectomy. Further, a short duration of administration of total parenteral nutrition and immediate postoperative initiation of oral feeding may prevent gallbladder complications after esophagectomy and total gastrectomy.
Department of Surgery, Yokohama Central Hospital, Yokohama, Japan. ooida.takatsugu@yokochu.jp
Takatsugu
T
Oida
Hisao
H
Kano
Kenji
K
Mimatsu
Atsushi
A
Kawasaki
Youichi
Y
Kuboi
Nobutada
N
Fukino
Kazutoshi
K
Kida
Sadao
S
Amano
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D002764:Cholecystitis / Q000209:etiology* / Q000517:prevention & control; D002779:Cholestasis / Q000209:etiology* / Q000517:prevention & control; D016629:Esophagectomy / Q000009:adverse effects*; D005260:Female; D005743:Gastrectomy / Q000009:adverse effects*; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010288:Parenteral Nutrition; D012189:Retrospective Studies